Factors related to the progression of Chronic Kidney Disease after two years of follow-up of stage 3 Chronic kidney Disease Patients

<p><strong>Background:</strong>The problem of chronic kidney disease (CKD) progression is a panic and it is still inevitable.</p><p><strong>Patients  and  Methods:</strong> Prospective  observational  study  of factors  present  at  initial  evaluation  of ...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Noemi Esparza Martín (Auteur), Santiago Suria González (Auteur), Elvira Bosch Benítez- Parodi (Auteur), Rita Guerra Rodríguez (Auteur), Germán Pérez Suárez (Auteur), César García Cantón (Auteur)
Format: Livre
Publié: Archives of Renal Diseases and Management - Peertechz Publications, 2017-08-29.
Sujets:
Accès en ligne:Connect to this object online.
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

MARC

LEADER 00000 am a22000003u 4500
001 peertech__10_17352_2455-5495_000027
042 |a dc 
100 1 0 |a Noemi Esparza Martín  |e author 
700 1 0 |a  Santiago Suria González  |e author 
700 1 0 |a  Elvira Bosch Benítez- Parodi  |e author 
700 1 0 |a  Rita Guerra Rodríguez  |e author 
700 1 0 |a  Germán Pérez Suárez  |e author 
700 1 0 |a César García Cantón  |e author 
245 0 0 |a Factors related to the progression of Chronic Kidney Disease after two years of follow-up of stage 3 Chronic kidney Disease Patients 
260 |b Archives of Renal Diseases and Management - Peertechz Publications,   |c 2017-08-29. 
520 |a <p><strong>Background:</strong>The problem of chronic kidney disease (CKD) progression is a panic and it is still inevitable.</p><p><strong>Patients  and  Methods:</strong> Prospective  observational  study  of factors  present  at  initial  evaluation  of  stage  3  CKD  patients proceeding  from  external  consultations  after  two  years  of follow-up. Exclusion criteria: Under 40 or older than 79 years old,  anemia,  previous  heart  or  hepatic  failure,  valvular  or  ischemic cardiopathy, arrhythmias, clinical arterial peripheral disease  or  immunosuppressive  treatment.  Inclusion  criteria: All  the  incidental  patients  who  wish  to  participate  between January,  2012  and  January,  2014.  The  study  was  approved  by the Committee of Ethics of Clinical Investigation. </p> 
540 |a Copyright © Noemi Esparza Martín et al. 
546 |a en 
655 7 |a Abstract  |2 local 
856 4 1 |u https://doi.org/10.17352/2455-5495.000027  |z Connect to this object online.